P R E M I U M

GLP-1 | Thursday, August 7

Novo Nordisk Dances on Lilly’s Experimental Weight-Loss Pill Misses


Eli Lilly’s pill stumbles on efficacy and side effects, pumping Wall Streets love of Novo’s GLP-1.


try moby for free

There's a reason why over 15 million investors love Moby, try for free today